Takeda Pharmaceutical
TAK
#470
Rank
HK$356.46 B
Marketcap
HK$114.12
Share price
1.11%
Change (1 day)
11.47%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2024 (TTM): HK$17.41 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.97 Billion. a decrease over its 2023 earnings that were of HK$17.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2024

Annual earnings

Year Earnings Change
2024 HK$17.54 B-1.9%
2023 HK$17.88 B-28.11%
2022 HK$24.87 B-41.15%
2021 HK$42.27 B78.15%
2020 HK$23.72 B246.83%
2019 HK$6.84 B-48.74%
2018 HK$13.34 B-23.86%
2017 HK$17.53 B21.77%
2016 HK$14.39 B-253.22%
2015 -HK$9.4 Billion-159.7%
2014 HK$15.73 B12.76%
2013 HK$13.95 B2.7%
2012 HK$13.59 B-57.11%
2011 HK$31.68 B-10.11%
2010 HK$35.24 B-4.2%
2009 HK$36.79 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$214.66 B 1,123.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$68.77 B 291.97%๐Ÿ‡ซ๐Ÿ‡ท France
HK$80.99 B 361.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$116.84 B 565.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$6.2 Billion-135.29%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.89 B-60.71%๐Ÿ‡ฎ๐Ÿ‡ณ India
HK$52.08 B 196.87%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.38 B 141.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$168.00 B 857.57%๐Ÿ‡บ๐Ÿ‡ธ USA